New research published in the peer-reviewed journal Cureus (part of the Springer Nature Group) shows that ivermectin helped save millions of lives in Peru, where during the Wuhan coronavirus (Covid-19) "pandemic" the government authorized its use.
Unlike in the United States where ivermectin prescriptions were essentially banned – some U.S. doctors were threatened that they would lose their medical license if they continued prescribing ivermectin to patients – the government of Peru decided that ivermectin just might be what the doctor ordered. It turns out they were right.
Published on August 8, the paper highlights a 74 percent reduction in excess deaths across the 10 Peruvian states that saw the most intensive ivermectin use over a 30-day period immediately following the plandemic's peak deaths timeframe.
Across all 25 states in Peru, scientists found that excess deaths closely correlated to ivermectin use – meaning the more people who used ivermectin, and the more ivermectin people used, the lesser the number of excess deaths across the board.
"When ivermectin was available without restriction, there was a fourteenfold reduction in nationwide excess deaths," reported The Epoch Times about the study's findings.
(Related: Earlier this year, a gold standard randomized controlled trial found that ivermectin does, in fact, work against covid.)
After Peruvian government restricted ivermectin use, excess deaths shot right back up
Things were not rosy in Peru for the entirety of the scamdemic, though. At one point, the Peruvian government imposed new restrictions on the use of ivermectin in accordance with globalist dictates. This resulted in a thirteenfold increase in excess deaths in the first two months following the ban.
The World Health Organization (WHO) similarly confirmed that once Peru withdrew access to ivermectin across its population, people started dying in increasingly greater numbers.
It is actually quite strange what Peru did by first promoting the use of ivermectin, only to later restrict it. It seems the actual government there may have wanted to help the people, while the shadow government that actually pulls the strings decided that helping people with this safe, effective, and inexpensive generic drug was no longer permissible.
"Ivermectin is a widely-known and inexpensive treatment against parasitic diseases," the Times reported. "Scientists believe the drug can also bind to the spike protein of the SARS-CoV-2 virus, limiting its morbidity and infectivity."
It was May 8, 2020, when the Peruvian Ministry of Health approved the use of ivermectin as both an inpatient and outpatient treatment protocol. Mega-Operación Tayta (MOT), a national program led by Peru's Ministry of Defense, was tasked with distributing the drug on a wide scale during that time.
Via a partnership with 11 other government agencies, the MOT sought to reach every targeted region with ivermectin rapid response teams. This is how seriously the Peruvian government, at least in the beginning, believed that ivermectin would help to save lives.
Then, something bad happened. On Nov. 17, 2020, President Francisco Sagasti, who had just taken office, stopped all distribution of ivermectin and made it available only by prescription – the U.S. is one of the only countries where ivermectin is prescription-only, while the rest of the world sells it cheaply over the counter.
"Results showed that the 10 MOT states had a sharp decrease in excess deaths after reaching peak values – with a 74 percent drop at 30 days and an 86 percent drop at 45 days after the date of peak deaths," reports indicate.
"For 14 states that locally administered ivermectin, excess deaths dropped by 53 percent at 30 days and 70 percent at 45 days."
"Once access to ivermectin was restricted by the government, a thirteenfold increase in excess deaths was observed in the two months following the limitation of its use."
Ivermectin works to prevent and treat covid – without the need for vaccines. Learn more at IvermectinScience.com.
Sources for this article include:
Please contact us for more information.